U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06984640) titled 'Curcumin Supplementation for the Improvement of Diabetes-related Outcomes' on May 14.
Brief Summary: The goal of this clinical trial is to learn about, test, and compare health outcomes of curcumin supplementation (400 mg). Two primary hypotheses are:
1. Curcumin supplementation will improve glycemic control in older adults with pre-diabetic conditions over a 12-week period.
* Rationale: Curcumin has been shown to enhance insulin sensitivity, reduce fasting blood glucose, and lower HbA1c levels in preclinical and clinical studies. This hypothesis will be tested by measuring changes in fasting glucose, insulin levels, and diabetic b...